Although there are many choices modality, the level 1 clinical evidence now supports the use of pharmacologic therapy with anticoagulants Low-Molecular Weight Heparin (LMWH) for primary DVT prophylaxis agent. Different types of LMWH have different indications approved by the Food and Drug Administration...
By the use of 125I-labeled test, the incidence of (DVT) and the effectiveness of prophylactic low-dose treatment were investigated in 110 patients who unde... GBFPS Group - 《Lancet》 被引量: 209发表: 1996年 Randomised high- and low-dose heparin prophylaxis in patients undergoing thoracotomy...
To compare the effectiveness and safety of low-dose unfractionated heparin and a low-molecular-weight heparin as prophylaxis against venous thromboembolism after colorectal surgery. In a multicenter, double-blind trial, patients undergoing resection of part or all of the colon or rectum were randomized...
aData support the use of low dose heparin, low molecular weight heparin*, coumadin, and mechanized compression stockings. Always check with surgeon to discuss choice of DVT prophylaxis Meta-analysis (of elective hip replacement studies) supports starting low molecular weight heparin pre-op versus ...
prophylaxis and treatment ofDVTandpulmonary embolismassociated with hematologic disorders (leukemia,sickle cell anemia, hypercoagulable states); 2. antiphospholipid syndrome; 3. bone marrow transplantation associated vasculopathies; 4. congenital and acquiredthrombophlebitis; and ...
LONG TERM PROPHYLAXIS OF THROMBOEMBOLISM IN OUTPATIENTS WITH LOW MOLECULAR WEIGHT HEPARIN The prophylaxis of thromboembolism with oral anticoagulants and low dose heparin is established. However, bleeding episodes and other side effects may occur. Alternative compunds for further anticoagulation do not exist...
In a prospective, randomized multicentre trial the safety and efficacy of two regimens of a low molecular weight heparin (nadroparin calcium) were compared for the prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in orthopaedic trauma patients. Two hundred and eighty-three patie...
Low-molecular weight heparins (e.g. enoxaparin) do not require PTT or aPTT monitoring.DVT prophylaxis, angina unstable.Monitor for bleeding. Usual Lovenox dose 30-40mg SC q day x7-10 days, start 12 hrs preop.May continue 40mg SC q day x3 weeks as extended prophylaxis....
[0072] Low molecular weight heparins (LMWHs) are obtained from standard unfractionated heparin (UFH), and have been used for the prophylaxis and treatment of venous thromboembolism (see, e.g. Schafer, A. I., Hospital Practice Jan. 15, 1997, pp. 99-106). LMWHs have also be used in ...
BMI ≥ 40 or < 16.5 kg/m2, were not on standard dosing of either enoxaparin or UFH, switched to a different type of pharmacological DVT prophylaxis during ICU stay (from enoxaparin to UFH and vice versa), underwent dose adjustment for pharmacological VTE prophylaxis A l Sulai...